L, Z., PA, C., JM, S., CL, S., HC, R., O, K., . . . M, D. (2026). Radiopharmaceutical therapy provides superior survival advantage for leptomeningeal metastasis compared to external beam radiotherapy. Neuro-oncology. https://doi.org/10.1093/neuonc/noag098
Chicago Style (17th ed.) CitationL, Zhao, et al. "Radiopharmaceutical Therapy Provides Superior Survival Advantage for Leptomeningeal Metastasis Compared to External Beam Radiotherapy." Neuro-oncology 2026. https://doi.org/10.1093/neuonc/noag098.
MLA (9th ed.) CitationL, Zhao, et al. "Radiopharmaceutical Therapy Provides Superior Survival Advantage for Leptomeningeal Metastasis Compared to External Beam Radiotherapy." Neuro-oncology, 2026, https://doi.org/10.1093/neuonc/noag098.
Warning: These citations may not always be 100% accurate.
